Trial · NCT07894562
Efficacy of MAGNESIO TOTAL on Sleep Quality and Quality of Life in Adults
NCT07894562, Not applicable, Active not recruiting, José Enrique de la Rubia Ortí, Ph
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Efficacy of MAGNESIO TOTAL on Sleep Quality and Quality of Life in Adults. Trials, record NCT07894562. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07894562
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Efficacy of MAGNESIO TOTAL on Sleep Quality and Quality of Life in Adults
- NCT number
- NCT07894562
- Status
- Active not recruiting
- Phases
- Not applicable
- Enrollment
- 50 participants, actual
- Lead sponsor
- José Enrique de la Rubia Ortí, Ph
- Conditions
- Sleep Quality, Magnesium Deficiency, Sleep Initiation and Maintenance Disorders, Quality of Life
- Interventions
- Magnesium bisglycinate and magnesium malate, Placebo
- First posted
- 2026-10-26
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes24
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in sleep quality measured by the Pittsburgh Sleep Quality Index (PSQI) | Baseline (week 0) and week 8 | Global PSQI score (sum of 7 components, each 0-3). Range 0-21; higher scores indicate worse sleep quality. Change from baseline to week 8 compared between groups. |
| Primary | Change in insomnia severity measured by the Insomnia Severity Index (ISI) | Baseline (week 0) and week 8 | ISI total score (7 items, each 0-4). Range 0-28; higher scores indicate greater insomnia severity (0-7 no clinically significant insomnia, 8-14 subthreshold, 15-21 moderate, 22-28 severe). |
| Primary | Change in health-related quality of life measured by the EQ-5D-5L index | Baseline (week 0) and week 8 | EQ-5D-5L descriptive system (mobility, self-care, usual activities, pain/discomfort, anxiety/depression; each rated on 5 levels), converted into a utility index using the Spanish value set. Index values up to 1 (full health); higher values indicate better health-related quality of life. |
| Primary | Change in self-rated health measured by the EQ visual analogue scale (EQ VAS) | Baseline (week 0) and week 8 | EQ VAS from the EQ-5D-5L questionnaire. Range 0 (worst imaginable health) to 100 (best imaginable health); higher scores indicate better self-rated health. |
| Secondary | Change in total sleep duration | Baseline (week 0) and week 8 | Self-reported total hours of actual sleep per night during the past month, obtained from the PSQI (hours). |
| Secondary | Change in sleep onset latency | Baseline (week 0) and week 8 | Self-reported time (minutes) needed to fall asleep each night during the past month, obtained from the PSQI. |
| Secondary | Change in habitual sleep efficiency | Baseline (week 0) and week 8 | Sleep efficiency (%) calculated as hours slept divided by hours spent in bed x 100, obtained from the PSQI. Higher values indicate better sleep efficiency. |
| Secondary | Change in body mass index (BMI) | Baseline (week 0) and week 8 | BMI (kg/m\^2) calculated from body weight (kg), measured fasting with light clothing on a calibrated scale, and height (cm), measured with a fixed stadiometer. |
| Secondary | Change in waist circumference | Baseline (week 0) and week 8 | Waist circumference (cm) measured at the midpoint between the lower rib margin and the iliac crest, standing, at the end of a normal expiration, with an inextensible tape. |
| Secondary | Change in systolic blood pressure | Baseline (week 0) and week 8 | Systolic blood pressure (mmHg) measured seated after at least 5 minutes of rest with a validated device; three readings 1 minute apart, using the mean of the last two. |
1 to 10 of 24Source ClinicalTrials.gov
See all 24 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07894562
GET https://conductscience.org/api/trials/v1/NCT07894562/registered?page=2